KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Cash from Operations (2016 - 2025)

Globus Medical's Cash from Operations history spans 15 years, with the latest figure at 248587000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 18.18% year-over-year to 248587000.0; the TTM value through Dec 2025 reached 753447000.0, up 44.72%, while the annual FY2025 figure was 753447000.0, 44.72% up from the prior year.
  • Cash from Operations reached 248587000.0 in Q4 2025 per GMED's latest filing, roughly flat from 249695000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 249695000.0 in Q3 2025 to a low of 32920000.0 in Q3 2022.
  • Average Cash from Operations over 5 years is 98616300.0, with a median of 63772500.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: crashed 57.39% in 2022, then soared 303.4% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 76253000.0 in 2021, then decreased by 16.1% to 63975000.0 in 2022, then surged by 63.62% to 104674000.0 in 2023, then surged by 100.95% to 210339000.0 in 2024, then increased by 18.18% to 248587000.0 in 2025.
  • Per Business Quant, the three most recent readings for GMED's Cash from Operations are 248587000.0 (Q4 2025), 249695000.0 (Q3 2025), and 77865000.0 (Q2 2025).